EMERALD ADVISERS, LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.5%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2021$325,000
-97.5%
8,865
-96.9%
0.01%
-97.4%
Q1 2021$12,817,000
-30.9%
285,846
-12.1%
0.46%
-25.0%
Q4 2020$18,555,000
+36.7%
325,126
+22.9%
0.62%
+10.2%
Q3 2020$13,576,000
+12.7%
264,631
+31.2%
0.56%
+6.5%
Q2 2020$12,046,000
+182.6%
201,714
+94.9%
0.52%
+112.6%
Q1 2020$4,262,000
+1466.9%
103,510
+1192.3%
0.25%
+1800.0%
Q3 2019$272,000
-97.0%
8,010
-98.0%
0.01%
-96.4%
Q2 2019$8,984,000
-4.0%
398,421
-1.1%
0.36%
-5.2%
Q1 2019$9,354,000
-28.5%
403,034
-35.3%
0.38%
-40.7%
Q4 2018$13,075,000
-52.1%
622,904
-11.6%
0.64%
-35.8%
Q3 2018$27,279,000
+17.1%
704,514
+19.0%
1.00%
+14.0%
Q2 2018$23,304,000
+141.5%
592,224
+23.0%
0.88%
+127.1%
Q1 2018$9,648,000
-11.8%
481,439
-0.2%
0.39%
-8.1%
Q4 2017$10,941,000
+64.3%
482,626
+37.6%
0.42%
+55.4%
Q3 2017$6,661,000350,7400.27%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$69,030,00015.95%
SV Health Investors, LLC 449,951$25,679,00012.37%
Sunesis Advisors, LLC 96,299$5,496,0004.45%
Redmile Group, LLC 4,437,968$253,275,0003.07%
Consonance Capital Management LP 484,671$27,660,0002.58%
SECTORAL ASSET MANAGEMENT INC 488,842$27,898,0001.97%
Opaleye Management Inc. 222,000$12,670,0001.66%
Eversept Partners, LP 246,240$14,052,9171.65%
SILVERARC CAPITAL MANAGEMENT, LLC 38,620$2,204,0001.28%
Avoro Capital Advisors LLC 1,300,000$74,191,0001.28%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders